Lotus Pharmaceuticals (LTUS) Stock Chart & Stock Price History → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free LTUS Stock Alerts $0.0046 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Lotus Pharmaceuticals Stock Price Performance5 Day PerformanceN/A1 Month PerformanceN/A3 Month PerformanceN/A6 Month Performance-23.33%Year-To-Date Performance+6.98%1 Year PerformanceN/A Receive LTUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lotus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. LTUS Stock Chart for Saturday, June, 1, 2024 LTUS Chart by TradingView Lotus Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$0.00$0.00$0.00$0.0010,000 shs$12.66 million05/30/2024$0.00$0.00-2.65%$0.00$0.0010,000 shs$12.66 million05/20/2024$0.00$0.00$0.00$0.0050 shs$12.66 million05/17/2024$0.00$0.00+17.83%$0.00$0.00150 shs$10.78 million05/16/2024$0.00$0.00$0.00$0.002 shs$10.78 million05/15/2024$0.00$0.00$0.00$0.002 shs$10.78 million Get the Latest News and Ratings for LTUS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lotus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$0.00$0.00+0.25%$0.00$0.00150 shs$13.47 million05/08/2024$0.01$0.00-20.00%$0.00$0.00150 shs$13.47 million04/26/2024$0.01$0.01$0.01$0.0110,000 shs$13.47 million04/25/2024$0.01$0.01$0.01$0.0139,766 shs$13.47 million04/24/2024$0.01$0.01$0.01$0.0039,766 shs$13.47 million04/23/2024$0.01$0.01-28.57%$0.01$0.0039,766 shs$13.47 million04/12/2024$0.01$0.01$0.01$0.01975 shs$18.86 million04/11/2024$0.01$0.01+40.00%$0.01$0.01975 shs$18.86 million04/10/2024$0.01$0.01$0.01$0.011,100 shs$13.47 million04/05/2024$0.01$0.01$0.01$0.011,000 shs$13.47 million04/04/2024$0.01$0.01$0.01$0.01100 shs$13.47 million03/26/2024$0.01$0.01$0.01$0.011,000 shs$13.47 million03/25/2024$0.00$0.01+25.00%$0.01$0.011,000 shs$13.47 million03/20/2024$0.00$0.00$0.01$0.0090,000 shs$10.78 million03/19/2024$0.01$0.00-46.67%$0.01$0.0090,000 shs$10.78 million03/18/2024$0.01$0.01$0.01$0.011,200 shs$20.21 million03/15/2024$0.01$0.01+36.36%$0.01$0.011,280 shs$20.21 million03/12/2024$0.01$0.01$0.01$0.0152,825 shs$14.82 million03/11/2024$0.01$0.01-11.29%$0.01$0.0110,000 shs$14.82 million03/08/2024$0.01$0.01-11.43%$0.01$0.011,500 shs$16.71 million03/07/2024$0.01$0.01$0.01$0.0110,000 shs$18.86 million03/06/2024$0.00$0.01+75.00%$0.01$0.0110,000 shs$18.86 million Related Companies: KZR Stock Price Chart LEXX Stock Price Chart CASI Stock Price Chart EQ Stock Price Chart KRON Stock Price Chart DARE Stock Price Chart CLNN Stock Price Chart NBRV Stock Price Chart NXTC Stock Price Chart HSTC Stock Price Chart Receive LTUS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lotus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:LTUS) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lotus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
